Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags

被引:9
作者
Chen, Fu-Chao [1 ]
Xiong, Hui [2 ]
Liu, Hui-Min [3 ]
Fang, Bao-Xia [4 ]
Li, Peng [4 ]
机构
[1] Hubei Univ Med, Dongfeng Hosp, Dept Clin Pharm, Shiyan, Peoples R China
[2] Hubei Univ Med, Renmin Hosp, Dept Pharm, Shiyan, Peoples R China
[3] Dongfeng Hosp, Dept Clin Pharm, Beijing, Peoples R China
[4] Dongfeng Hosp, Dept Pharm, Beijing, Peoples R China
关键词
PATIENT-CONTROLLED ANALGESIA; RECEPTOR ANTAGONISTS;
D O I
10.2146/ajhp140824
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The stability of admixtures containing butorphanol and granisetron in polyolefin bags and glass bottles stored at 4 and 25 degrees C was studied. Methods. Commercial solutions of butorphanol tartrate and granisetron hydrochloride were combined and further diluted with 0.9% sodium chloride injection to final concentrations of butorphanol tartrate 0.08 mg/mL and granisetron 0.03 or 0.06 mg/mL; the resulting mixtures were packaged in polyolefin bags and glass bottles. The admixtures were assessed for periods of up to 48 hours after storage at 25 C without protection from room light and up to 14 days at 4 degrees C with protection from room light. The chemical stability of the admixtures was evaluated by a validated high-performance liquid chromatography (HPLC) method and by measurement of pH values. Solution appearance and color were assessed by observing the samples against room light and dark backgrounds. Results. HPLC analysis demonstrated that the percentages of the initial concentrations of butorphanol and granisetron in the various solutions remained above 97% during the testing period. No changes in color or turbidity were observed in any of the prepared solutions. Throughout this period, pH values remained stable. Conclusion. Admixtures of butorphanol tartrate 0.08 mg/mL and granisetron 0.03 or 0.06 mg/mL in 0.9% sodium chloride injection in polyolefin bags or glass bottles remained stable for 48 hours when stored at 25 degrees C exposed to room light and for 14 days when stored at 4 degrees C protected from room light.
引用
收藏
页码:1374 / 1378
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2002, STAD BUT TARTR INJ P
[2]  
[Anonymous], 2014, GRAN HYDR INJ PRESCR
[3]   Stability of Butorphanol-Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use [J].
Chen, Fu-Chao ;
Shi, Xiao-Ya ;
Li, Peng ;
Yang, Jin-Guo ;
Zhou, Ben-Hong .
MEDICINE, 2015, 94 (06) :1-5
[4]   Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection [J].
Chen, Fu-Chao ;
Fang, Bao-Xia ;
Li, Peng ;
Yang, Jin-Guo ;
Zhou, Ben-Hong .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (06) :515-519
[5]   Butorphanol:: Effects of a prototypical agonist-antagonist analgesic on κ-opioid receptors [J].
Commiskey, S ;
Fan, LW ;
Ho, IK ;
Rockhold, RW .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 98 (02) :109-116
[6]  
Fang BX, 2013, CENT S PHARM, V11, P732
[7]   A Review of Granisetron, 5-Hydroxytryptamine3 Receptor Antagonists, and Other Antiemetics [J].
Hsu, Eric S. .
AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (05) :476-486
[8]   USP chapter 797:: Establishing a practice standard for compounding sterile preparations in pharmacy [J].
Kastango, ES ;
Bradshaw, BD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (18) :1928-1938
[9]   A Network Meta-Analysis on the Efficacy of Serotonin Type 3 Receptor Antagonists Used in Adults During the First 24 Hours for Postoperative Nausea and Vomiting Prophylaxis [J].
Tang, Derek H. ;
Malone, Daniel C. .
CLINICAL THERAPEUTICS, 2012, 34 (02) :282-294
[10]  
Trissel L A Bs Rph, 2001, Int J Pharm Compd, V5, P314